U.S. drug distributors prevail in $2.5 billion West Virginia opioid case

2022.07.05 01:25

FILE PHOTO: Tablets of the opioid-based Hydrocodone at a pharmacy in Portsmouth, Ohio, June 21, 2017. REUTERS/Bryan Woolston/File Photo

(Reuters) – McKesson Corp (NYSE:MCK), AmerisourceBergen (NYSE:ABC) Corp and Cardinal Health Inc (NYSE:CAH) are not responsible for fueling an opioid epidemic in a part of West Virginia, a federal judge ruled on Monday.

The decision from U.S. District Judge David Faber came in a $2.5 billion case brought by the city of Huntington and Cabell County, which sought to hold the three largest U.S. drug distributors responsible for surging opioid prescriptions in their communities.

Source